From Personal Struggle to a $26M Powerhouse: The Allara Story

Imagine growing up with an OB-GYN father, thinking every woman had access to top-tier gynecological care. That was Rachel Blank’s reality—until her own health journey shattered that illusion. At 21, Blank was diagnosed with polycystic ovary syndrome (PCOS), a hormonal condition that affects millions of women worldwide. Despite her privileged access to healthcare, she discovered a glaring gap: most OB-GYNs aren’t trained to treat hormonal conditions like PCOS. “There weren’t a lot of places for me to go,” Blank told TechCrunch. “The concept of a specialist for my condition didn’t exist.”

Blank’s journey to find treatment was a patchwork of specialists—dieticians, endocrinologists, and more. Frustrated by the lack of cohesive care, she left her role as a strategy director at Ro (a telehealth giant for men’s health) to launch Allara, a telehealth platform dedicated to women with hormonal conditions like PCOS, endometriosis, and hypothyroidism. Allara brings together the fragmented care Blank once pieced together herself, offering a one-stop solution for women who’ve been underserved by traditional healthcare systems.

Why Allara is Crushing It

Allara isn’t just another telehealth startup—it’s a movement. In 2024, the company quadrupled its revenue and secured a whopping $26 million in Series B funding, led by Index Ventures with participation from GV. This comes just 14 months after their $10 million Series A. The secret sauce? Allara’s laser focus on young women, with an average patient age of 30, and its ability to deliver comprehensive care that traditional systems can’t match.

• Insurance Expansion: Allara has partnered with major providers like Aetna, Blue Cross Blue Shield, and United Healthcare, covering services in 10 states. The Series B funding will fuel nationwide expansion.
• Remote Care for Providers: Doctors, nurse practitioners, and dietitians—many of whom are working mothers—love the flexibility of remote care. No more commuting to clinics; they can deliver life-changing care from home.
• Chronic Conditions First: While competitors like Tia and Ro focus on infertility or menopause, Allara targets younger women dealing with chronic hormonal conditions. This early engagement builds lifelong patient relationships.

“If you have a relationship with your care providers since you are 20 or 25, it is very natural to stay over time.”

Martin Mignot, Partner at Index Ventures

The Future of Allara: Beyond Hormones

Allara’s success isn’t just about treating PCOS or endometriosis—it’s about building trust with patients early. As these women grow older, Allara plans to expand into infertility and menopause care, creating a seamless healthcare journey. “This is just the beginning,” Blank says. “We’re here to redefine women’s health, one hormone at a time.”

With $26 million in the bank and a mission that resonates with millions, Allara is poised to dominate the telehealth space. For women who’ve been overlooked by traditional healthcare, Allara isn’t just a platform—it’s a lifeline.